“…This would provide important information with respect to various developing systems, including the brain (Dupe et al, 1999;Smith et al, 2001;Sirbu et al, 2005;Ribes et al, 2006;Molotkova et al, 2007), sensory organs Matt et al, 2005;Molotkov et al, 2006;Romand et al, 2006), cranial neural crest cells and branchial arch derivatives (Wendling et al, 2000;Niederreither et al, 2003;Mark et al, 2004), and heart (Merki et al, 2005;Ryckebusch et al, 2008;Sirbu et al, 2008). Retinoids are also potent teratogenic compounds in human (Lammer et al, 1985;Hanson and Leachman, 2001;Charakida et al, 2004, and references therein), and excess RA administration affects many morphogenetic processes in mice (e.g., Kessel and Gruss, 1991;Marshall et al, 1992;Shum et al, 1999;Matt et al, 2003). Thus, it is equally important to be able to identify and trace the fate of cells that have not been in contact with RA, to clarify whether teratogenesis mediated by RA results from ectopic signaling in tissues that are normally devoid of retinoids.…”